Skip to content
Top Menu
  • Log In
  • Register
  • Facebook
  • Twitter
  • LinkedIn
MyChesCo

MyChesCo

Chester County News and Community Website

  • Communities
    • Avondale
    • Berwyn
    • Coatesville
    • Cochranville
    • Devon
    • Downingtown
    • Exton
    • Honey Brook
    • Kennett Square
    • Malvern
    • Oxford
    • Paoli
    • Parkesburg
    • Phoenixville
    • Spring City
    • Toughkenamon
    • West Chester
    • West Grove
  • Education
    • Chester County Intermediate Unit
    • School Districts
      • Avon Grove School District
      • Coatesville Area School District
      • Downingtown Area School District
      • Great Valley School District
      • Kennett Consolidated School District
      • Octorara Area School District
      • Owen J. Roberts School District
      • Oxford Area School District
      • Phoenixville Area School District
      • Spring-Ford Area School District
      • Tredyffrin-Easttown School District
      • Twin Valley School District
      • Unionville-Chadds Ford School District
      • West Chester Area School District
    • Charter Schools
    • Independent Schools
    • Colleges and Universities
    • Chester County Library System
  • News
    • Traffic
    • Weather
    • Business
    • Health / Medical
    • National
    • Pennsylvania
    • Sports
  • Entertainment
  • Lifestyle
  • Tools
    • Members
    • Groups
    • Submit an Article
    • Contact Us
    • Signup for Newsletter
    • Contests and Giveaways
    • Gas Prices
    • Register
    • Log In
  • About
    • MyChesCo
    • Writing for Us
    • Advertising with Us
    • Contacting Us
    • Citizen Journalism
    • Submitting Articles
    • Starting a Group
    • How to Support Us
    • Terms of Service
    • Privacy Policy
    • DMCA Policy
    • AI Disclosure
  • Shop

Wilmington Business News

AstraZeneca
Cancer / Regional

Tagrisso Cuts Death Risk 47% in Long-Term Lung Cancer Trial

September 21, 2026September 20, 2026 - by Timothy Alexander

WILMINGTON, DE — AstraZeneca’s (NYSE: AZN) Tagrisso showed a sustained survival benefit eight years after treatment in a Phase III trial of patients with early-stage EGFR-mutated non-small cell lung cancer, …

Tagrisso Cuts Death Risk 47% in Long-Term Lung Cancer Trial Read More

Business News
Regional

Exicure Gets Nasdaq Extension as Delisting Risk Persists

September 20, 2026September 19, 2026 - by Timothy Alexander

WILMINGTON, DE — Exicure Inc. (Nasdaq: XCUR) has until Dec. 2 to restore compliance with Nasdaq’s minimum stockholders’ equity requirement, giving the company additional time to address a listing deficiency …

Exicure Gets Nasdaq Extension as Delisting Risk Persists Read More
NRx Pharmaceuticals
Regional

NRx Gets Earlier FDA Goal Date for Ketamine Application

September 20, 2026September 19, 2026 - by Timothy Alexander

WILMINGTON, DE — NRx Pharmaceuticals Inc. (Nasdaq: NRXP) received a revised Nov. 10 regulatory goal date for its preservative-free ketamine application after the U.S. Food and Drug Administration reclassified a …

NRx Gets Earlier FDA Goal Date for Ketamine Application Read More

Chase
Regional

Chase, Air Canada Raise Rewards Stakes on Aeroplan Card

September 20, 2026September 19, 2026 - by Timothy Alexander

WILMINGTON, DE — Chase and Air Canada are expanding rewards and travel benefits on the Chase Air Canada Aeroplan Card, increasing earn rates and adding automatic elite status as competition …

Chase, Air Canada Raise Rewards Stakes on Aeroplan Card Read More
Uplynk
Regional

Uplynk Targets Streaming Complexity With AWS Managed Layer

September 19, 2026September 18, 2026 - by Timothy Alexander

WILMINGTON, DE — Uplynk is adding a managed operations layer around AWS Elemental video infrastructure, targeting streaming providers that want to reduce the engineering work required to deploy and operate …

Uplynk Targets Streaming Complexity With AWS Managed Layer Read More

AstraZeneca
Regional / Research

AstraZeneca Lung Cancer Combo Extends Survival in Phase III

September 18, 2026September 17, 2026 - by Timothy Alexander

WILMINGTON, DE — AstraZeneca’s Imfinzi combined with Amgen’s tarlatamab significantly extended overall survival in a Phase III trial of first-line extensive-stage small cell lung cancer, potentially expanding treatment options for …

AstraZeneca Lung Cancer Combo Extends Survival in Phase III Read More
AstraZeneca
Regional / Research

AstraZeneca COPD Drug Cuts Exacerbations in Phase III

September 18, 2026September 17, 2026 - by Timothy Alexander

WILMINGTON, DE — AstraZeneca’s experimental COPD drug tozorakimab reduced moderate and severe exacerbations by as much as 34% in two Phase III trials across a broad patient population, supporting a …

AstraZeneca COPD Drug Cuts Exacerbations in Phase III Read More

Diversified LLC
Regional

Diversified Named to Best Places to Work by Quartz 2026

September 17, 2026September 16, 2026 - by Laron Gray

WILMINGTON, DE — Diversified, LLC, a registered investment advisor, has been named to Quartz’s Best Places to Work 2026 list, which recognizes eight U.S. companies for how they are run …

Diversified Named to Best Places to Work by Quartz 2026 Read More
NRx Pharmaceuticals
Regional

HOPE Adds Robotic TMS System Ahead of SPARC Trial

September 15, 2026September 14, 2026 - by Timothy Alexander

WILMINGTON, DE — NRx Pharmaceuticals Inc. said its HOPE Therapeutics subsidiary will become the first interventional psychiatry network to deploy Zeta Surgical’s newly FDA-cleared robotic transcranial magnetic stimulation system, expanding …

HOPE Adds Robotic TMS System Ahead of SPARC Trial Read More
Prelude Therapeutics
Regional / Research

Prelude Wins FDA Clearance to Move Breast Cancer Drug to Trial

September 15, 2026September 13, 2026 - by Timothy Alexander

WILMINGTON, DE — Prelude Therapeutics Inc. (Nasdaq: PRLD) received U.S. Food and Drug Administration clearance to begin a Phase 1 trial of PRT13722, moving its experimental KAT6A-targeting breast cancer drug …

Prelude Wins FDA Clearance to Move Breast Cancer Drug to Trial Read More

Posts pagination

Previous 1 … 9 10 11 … 87 Next

Trending News

  • Avon Grove Offers a Quieter, Sensory-Friendly Visit With Santa

  • Unionville-Chadds Ford Advances $164 Million School Project

  • Malvern Wreath Ceremony Honors 52 Fallen Revolutionary Soldiers

  • Ephrata Man Faces Child Sex Abuse Charges, $500K Bail

  • $534 Retail Theft Prompts Police Appeal in Wyomissing

Subscribe for Updates

Tools

  • Members
  • Newsletter
  • Events
  • Groups
  • Guest Articles
  • Coupon Center
  • Gas Prices
  • Log In
  • Register

About Us

  • About MyChesCo
  • Advertise
  • Contact Us
  • Support Us
  • Write for Us
  • Terms of Service
  • Privacy Policy
  • DMCA Policy
  • Affiliate Disclaimer

Recommended Reading

Vincenzo Azzarelli

Ephrata Man Faces Child Sex Abuse Charges, $500K Bail

November 18, 2026November 18, 2026

suspect

$534 Retail Theft Prompts Police Appeal in Wyomissing

November 18, 2026November 18, 2026

Matylda Szydelko

Woman Faces 10 Charges After Check Stolen From Mailbox

November 17, 2026November 17, 2026

Copyright © 2026 MyChesCo.